Efficacy and Safety of Mizoribine Combined With Losartan in the Treatment of IgA Nephropathy: A Multicenter, Randomized, Controlled Study

Yuansheng Xie(Chinese PLA General Hospital), Lining Wang(First Hospital of China Medical University), Lining Miao(Second Affiliated Hospital of Jilin University), Li Wang(Chengdu Women's and Children's Central Hospital), Ying Li(Wuxi People's Hospital), Songmin Huang(Xiangshan County First People's Hospital), Shuxin Liu(Chinese PLA General Hospital), Xiongfei Wu(Wuhan University), Xiangmei Chen(State Administration of Traditional Chinese Medicine of the People's Republic of China), Aiping Zhang(Yangzhou University), Pu Chen(University of Waterloo), Caihua Lie(Chinese PLA General Hospital)
The American Journal of the Medical Sciences
February 4, 2011
10.1097/maj.0b013e318207e02d
Cited by 15

Related Papers

Cellular Pharmacology and Molecular Biology of the Trabecular Meshwork Inducible glucocorticoid Response Gene Product
|Ophthalmologica|2010|375
Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
|International Journal of Biological Sciences|2022|350
5nm-gate nanowire FinFET
|Unknown|2004|249
Clinical characteristics of 82 death cases with COVID-19
|medRxiv|2020|249
The 2.5 Å Crystal Structure of the SIRT1 Catalytic Domain Bound to Nicotinamide Adenine Dinucleotide (NAD<sup>+</sup>) and an Indole (EX527 Analogue) Reveals a Novel Mechanism of Histone Deacetylase Inhibition
|Journal of Medicinal Chemistry|2013|218